Gold(I)-Catalyzed Cascade Approach for the Synthesis of Tryptamine-Based Polycyclic Privileged Scaffolds as alpha(1)-Adrenergic Receptor Antagonists
文献类型:期刊论文
作者 | Li, Zeng1; Li, Jing2![]() ![]() ![]() ![]() ![]() |
刊名 | JOURNAL OF ORGANIC CHEMISTRY
![]() |
出版日期 | 2013-11-01 |
卷号 | 78期号:21页码:10802-10811 |
ISSN号 | 0022-3263 |
DOI | 10.1021/jo4017887 |
文献子类 | Article |
英文摘要 | An efficient and facile gold(I)-catalyzed one-pot cascade protocol has been developed for the synthesis of tryptamine-fused polycyclic privileged structures through the treatment of substituted tryptamines and 2-ethynylbenzoic acids or 2-ethynylphenylacetic acids. This strategy features the formation of one C-C bond and two C-N bonds with high yields and broad substrate tolerance. The selected reduced target molecules are validated to perform as alpha(1)-adrenergic receptors antagonists. The most potent one, 4bh, exhibits an IC50 value of 277 nM on alpha(1A) subtype with a selectivity ratio of 15.8 over alpha(1B) subtype. |
WOS关键词 | BENIGN PROSTATIC HYPERPLASIA ; SELECTIVE PDE5 INHIBITOR ; URINARY-TRACT SYMPTOMS ; ALZHEIMERS-DISEASE ; INDOLE ALKALOIDS ; DRUG DISCOVERY ; LIGANDS ; GOLD ; ANALOGS ; AFFINITIES |
资助项目 | National Natural Science Foundation of China[21021063] ; National Natural Science Foundation of China[91229204] ; National Natural Science Foundation of China[81025017] ; National S&T Major Projects[2012ZX09103101-072] ; National S&T Major Projects[2012ZX09301001-005] |
WOS研究方向 | Chemistry |
语种 | 英语 |
WOS记录号 | WOS:000326615300022 |
出版者 | AMER CHEMICAL SOC |
源URL | [http://119.78.100.183/handle/2S10ELR8/277402] ![]() |
专题 | 国家新药筛选中心 药物化学研究室 |
通讯作者 | Xie, Xin |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Zeng,Li, Jing,Yang, Nan,et al. Gold(I)-Catalyzed Cascade Approach for the Synthesis of Tryptamine-Based Polycyclic Privileged Scaffolds as alpha(1)-Adrenergic Receptor Antagonists[J]. JOURNAL OF ORGANIC CHEMISTRY,2013,78(21):10802-10811. |
APA | Li, Zeng.,Li, Jing.,Yang, Nan.,Chen, Ying.,Zhou, Yu.,...&Liu, Hong.(2013).Gold(I)-Catalyzed Cascade Approach for the Synthesis of Tryptamine-Based Polycyclic Privileged Scaffolds as alpha(1)-Adrenergic Receptor Antagonists.JOURNAL OF ORGANIC CHEMISTRY,78(21),10802-10811. |
MLA | Li, Zeng,et al."Gold(I)-Catalyzed Cascade Approach for the Synthesis of Tryptamine-Based Polycyclic Privileged Scaffolds as alpha(1)-Adrenergic Receptor Antagonists".JOURNAL OF ORGANIC CHEMISTRY 78.21(2013):10802-10811. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。